₹ 10.25
-0.03 (-0.29%)
N
Nectar Lifesciences
₹ 10.25
NECLIFE Financials Summary (Consolidated)
Nectar Lifesciences revenue decreased 47.62% quarter-on-quarter to ₹3 Cr in Jun 2026, while net loss narrowed to ₹15 Cr from ₹68 Cr in the previous quarter. Compared to the same quarter last year, revenue is down 41.07% and net loss narrowed to ₹15 Cr from ₹63 Cr a year ago. EPS for the quarter stood at -₹0.79, increased from -₹3.38 in the previous quarter and up from -₹2.82 a year ago.
Nectar Lifesciences Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of NECLIFE Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
NECLIFE Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






